¡¡µ­»ö¥¿¥¤¥È¥ë¡§ÄËÉ÷¸¦½¤²ñ¤Ë»²²Ã¤·¤Æ¡¡


½ñ¤­¹þ¤ßÍó¤Ø ¡¡¥Ø¥ë¥×
¤ªÌ¾Á°¡§ ÀÖ¿¿½¨¿Í ¡¡¡¡
º£¤â¿Ê¹ÔÃæ¤Î»ä¤¿¤Á¤Î¥í¥µ¥ë¥¿¥ó¤È¥¢¥à¥í¥¸¥Ô¥ó¤Îrandomized controlled study¤Ç¡¢
¥¢¥à¥í¥¸¥Ô¥ó¤Ç¤â·ìÀ¶Ç¢»ÀÃͤ¬¾¯¤·²¼¤¬¤Ã¤Æ¤¤¤Þ¤¹¡£Ëܿͤ諤¨¤Ê¤¤ÅØÎϤ⤢¤ë¤Î¤Ç¤·¤ç¤¦¤¬¡¢
¶Ú¸¶À­¹âÇ¢»À·ì¾É¤ò²þÁ±¤·¤Æ¤¤¤ë¤Î¤«¤âÃΤì¤Þ¤»¤ó¡£
[2001ǯ9·î28Æü 8»þ10ʬ8ÉÃ]

¤ªÌ¾Á°¡§ ³á»³¹À ¡¡¡¡
³á»³¤Ç¤¹¡£
ÄËÉ÷¸¦½¤²ñ¤Ç¤Î¹ÖµÄ¤ÎÃæ¤Ç¡¢Ä»¼èÂç³Ø
¤Îµ×α°ìϺÀèÀ¸¤ÎÏä˽ФƤ­¤¿¡¢¶ÚͳÍè
¤ÎÇ¢»À¤ÎÏä¬ÊÙ¶¯¤Ë¤Ê¤ê¤Þ¤·¤¿¡£

¥¤¥ó¥¹¥ê¥óÄñ¹³À­¤¬¤¢¤ë¤È¡¢¶ÚÆâ¤Ç·ùµ¤À­
Âå¼Õ¤¬Ð¶¿Ê¤·¡¢¥Ò¥Ý¥­¥µ¥ó¥Á¥ó¤¬Áý¤¨¡¢¶Ú¸¶À­
¹âÇ¢»À·ì¾É¤È¤Ê¤ë¡£

¹â·ì°µ¤Î¿Í¤Ç¡¢±¿Æ°¸å¤Ë¶ÚÆùÆâ¤Î¥Ò¥Ý¥­
¥µ¥ó¥Á¥ó¤¬¹â¤¯¤Ê¤ë¿Í¤¬¤¤¤Æ¡¢¤³¤Î¿Í¤¿
¤Á¤Ï±¿Æ°¸å¤Î·ì°µ¾å¾º¤¬¡¢¥Ò¥Ý¥­¥µ¥ó¥Á¥ó
¤¬¹â¤¯¤Ê¤é¤Ê¤¤¿Í¤ËÈæ¤ÙÂ礭¤¤¡£

¹â·ì°µ¤Î´µ¼Ô¤µ¤ó¤Î¶ÚÆâ¥Ò¥Ý¥­¥µ¥ó¥Á¥ó¤ò
¦Áblocker,¦Á¦Âblocker,ACEI,Ĺ»þ´ÖºîÍÑ·¿Ca-antagonist
¤Î¹ß°µºÞ¤Ï¤µ¤²¡¢¼ÂºÝ·ìÀ¶Ç¢»ÀÃͤⲼ¤²¤ë¡£
¡ÊATª¢¼õÍÆÂÎÙɹ³Ìô¤Ï¶ÚÆâ¥Ò¥Ý¥­¥µ¥ó¥Á¥ó¤òµÕ¤Ë¤¢¤²¤Æ¤¤¤¿¡ª¡Ë

¤È¤Î¤³¤È¤Ç¤·¤¿¡£

¶ÚÆùÆâ¤Çµ¯¤³¤ë·ùµ¤À­Âå¼Õ¤Ï¡¢²¿¤¬¥È¥ê¥¬¡¼¤Ê¤Î¤Ç¤·¤ç¤¦¡©
±¿Æ°¸å¤Î·ì°µ¤Î¾å¾º¤È´Ø·¸¤¬¤¢¤ë¤È¤¹¤ë¤È¡¢¶ÚÆùÆâ¤Î·ì¹ÔÆ°ÂÖ
¤Ç¤·¤ç¤¦¤«¡©

¶ÚÆùÎ̤¬Â¿¤¤¿ÍÄø¡¢±¿Æ°¤Ë¤è¤êÇ¢»À¤¬¹â¤¯¤Ê¤ê¤ä¤¹¤¤¤Î¤Ç¤·¤ç¤¦¤«¡©
[2001ǯ9·î25Æü 23»þ5ʬ9ÉÃ]

¤³¤Î¥Æ¡¼¥Þ¤Ë¤Ä¤¤¤Æ¤Îȯ¸À¤ò¤É¤¦¤¾¡£
»á̾
E-mail URL
¢¨¡¡½ñ¤­¹þ¤ß¤Ï¤´¼«Ê¬¤¬¤¤¤ì¤¿²þ¹Ô¡Ü¥«¥é¥àü¤Ç¤â¼«Æ°²þ¹Ô¤µ¤ì¤Þ¤¹¡£

¢¨È¾³Ñ¥«¥Ê¤Ï»ÈÍѤ·¤Ê¤¤¤è¤¦¤Ë¤·¤Æ¤¯¤À¤µ¤¤¡£Ê¸»ú²½¤±¤·¤Þ¤¹¡£
µ­»ö°ìÍ÷¤ËÌá¤ë